We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current IVRO market cap is 2.28M. The company's latest EPS is USD 0.0047 and P/E is 21.28.
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.11M | 1M | 854k | 793k | 811k |
| Operating Income | 32k | -27k | -117k | -25k | 68k |
| Net Income | 50k | 96k | 21k | 2k | 107k |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.54M | 1.63M | 1.51M | 1.53M | 1.95M |
| Total Liabilities | 212k | 202k | 68k | 79k | 381k |
| Total Equity | 1.33M | 1.43M | 1.44M | 1.46M | 1.57M |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22k | 32k | 40k | -58k | 98k |
| Investing | -36k | 12k | 685k | -817k | -38k |
| Financing | 107k | 101k | -15k | N/A | N/A |
| Market Cap | 2.28M |
| Price to Earnings Ratio | 21.28 |
| Price to Sales Ratio | 2.81 |
| Price to Cash Ratio | 5.46 |
| Price to Book Ratio | 1.45 |
| Dividend Yield | - |
| Shares Outstanding | 22.76M |
| Average Volume (1 week) | 5.53k |
| Average Volume (1 Month) | 13.33k |
| 52 Week Change | 98.61% |
| 52 Week High | 0.13 |
| 52 Week Low | 0.025 |
| Spread (Intraday) | 0.05 (36.08%) |
| Company Name | Invitro International (QB) |
| Address |
330 e. orangethorpe avenue placerville, california 92870 |
| Website | https://www.invitrointl.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
